Patents by Inventor Andre Larsen

Andre Larsen has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20250235625
    Abstract: A drug delivery device comprising a housing with an opening surrounded by an edge, an indicator member adapted to rotate relative to the housing during dose setting and expelling corresponding to an axis of rotation. A pattern is arranged on the indicator member and comprises a plurality of indicia indicating a rotational position of the indicator member relative to the housing. The edge comprises a scanner edge portion arranged generally in parallel with the axis of rotation. A line scanner is arranged at the scanner edge portion and adapted to scan a line formed portion of the indicator member observable in the opening as the indicator member rotates relative to the line scanner from a start rotational position to an end rotational position during dose setting and/or dose expelling thereby providing a plurality of line scan images allowing a set or expelled amount of drug to be calculated.
    Type: Application
    Filed: April 24, 2023
    Publication date: July 24, 2025
    Inventor: Andre Larsen
  • Patent number: 12239827
    Abstract: A drug delivery assembly comprising an indicator adapted to move during expelling of a dose amount of drug, the amount of movement being indicative of the size of the expelled dose amount, and electronic tracking sensor circuitry adapted to with pre-determined intervals to change the operative state from a sleep state to a low-power detection state and back to the sleep state. When in the detection state, the electronic sensor circuitry is adapted to detect motion of an activation component, and if motion of the activation component is detected, then change the operative state from the low-power detection state to a high-power measuring state in which the amount of motion of the indicator relative to the tracking means can be determined.
    Type: Grant
    Filed: May 16, 2019
    Date of Patent: March 4, 2025
    Assignee: Novo Nordisk A/S
    Inventor: Andre Larsen
  • Publication number: 20230321415
    Abstract: A capsule device (100) suitable for insertion into a lumen, such as a gastrointestinal lumen, of a subject. The capsule device (100) comprises: a capsule housing (110, 120), a drug chamber (B) configured to accommodate a drug substance, the drug chamber leading to a drug outlet (190),—an actuation chamber (A),—a movable separator (160) arranged between the actuation chamber and the drug chamber, wherein movement of the movable separator expels drug substance from the drug chamber (B) through the drug outlet (190), and—a gas generator (140, 150) configured actuatable to generate pressurized gas in the actuation chamber (A) for exerting mechanical load on the moveable separator (160) to expel the drug substance.
    Type: Application
    Filed: September 29, 2021
    Publication date: October 12, 2023
    Inventors: Brian Mouridsen, Drago Sticker, Aghiad Ghazal, Andre Larsen, Jacob Pyung Hwa Jepsen
  • Patent number: 11369746
    Abstract: A drug delivery device is provided comprising a housing having an exterior surface, drug ex-pelling means comprising an indicator member arranged to move corresponding to an action performed on or by the drug delivery device, and a carrier foil on which is formed or mounted an energy source, electronically controlled communication means, and a processor adapted to (i) receive input from the drug delivery device indicative of indicator member movement and (ii) control the communication means. The flexible carrier foil is mounted on the exterior of the housing, and the flexible carrier foil is covered at least in part by a sealing foil covering directly or indirectly the thereon formed or mounted components, whereby a sealed interior space for the components formed or mounted on the flexible carrier foil is formed between the housing exterior surface and the sealing foil.
    Type: Grant
    Filed: May 4, 2018
    Date of Patent: June 28, 2022
    Assignee: Novo Nordisk A/S
    Inventor: Andre Larsen
  • Patent number: 11357926
    Abstract: A drug delivery device is provided comprising a drug-filled cartridge or means for receiving a drug-filled cartridge, and drug expelling means comprising expelling means for expelling an amount of drug from the cartridge, and an indicator member arranged to move corresponding to an action performed on or by the drug delivery device. The device further comprises an energy source, wireless communication means, sensor means adapted to detect movement of the indicator member, and a processor adapted to (i) receive input from the drug delivery device indicative of indicator member movement and (ii) control the communication means to transmit a data signal comprising coded information derived from received input from the sensor means, wherein the wireless communication means is in the form of a sound transducer.
    Type: Grant
    Filed: May 4, 2018
    Date of Patent: June 14, 2022
    Assignee: Novo Nordisk A/S
    Inventor: Andre Larsen
  • Publication number: 20210299362
    Abstract: The invention relates to a needle assembly, comprising a needle hub with a sterility barrier with a matrix of tear lines to enhance puncture of the sterility barrier. The matrix of tear lines consists of a plurality of individual tear lines defining a plurality of flaps which each are bendable into the interior of the needle hub when the sterility barrier is punctured.
    Type: Application
    Filed: July 5, 2019
    Publication date: September 30, 2021
    Inventors: Abbas Atraktchi, Andre Larsen
  • Publication number: 20210228809
    Abstract: A drug delivery assembly comprising an indicator adapted to move during expelling of a dose amount of drug, the amount of movement being indicative of the size of the expelled dose amount, and electronic tracking sensor circuitry adapted to with pre-determined intervals to change the operative state from a sleep state to a low-power detection state and back to the sleep state. When in the detection state, the electronic sensor circuitry is adapted to detect motion of an activation component, and if motion of the activation component is detected, then change the operative state from the low-power detection state to a high-power measuring state in which the amount of motion of the indicator relative to the tracking means can be determined.
    Type: Application
    Filed: May 16, 2019
    Publication date: July 29, 2021
    Inventor: Andre Larsen
  • Publication number: 20210077736
    Abstract: A drug delivery device is provided comprising a housing having an exterior surface, drug ex-pelling means comprising an indicator member arranged to move corresponding to an action performed on or by the drug delivery device, and a carrier foil on which is formed or mounted an energy source, electronically controlled communication means, and a processor adapted to (i) receive input from the drug delivery device indicative of indicator member movement and (ii) control the communication means. The flexible carrier foil is mounted on the exterior of the housing, and the flexible carrier foil is covered at least in part by a sealing foil covering directly or indirectly the thereon formed or mounted components, whereby a sealed interior space for the components formed or mounted on the flexible carrier foil is formed between the housing exterior surface and the sealing foil.
    Type: Application
    Filed: May 4, 2018
    Publication date: March 18, 2021
    Applicant: Novo Nordisk A/S
    Inventor: Andre Larsen
  • Patent number: 10850041
    Abstract: A drug delivery device is provided comprising or adapted to receive a cartridge with an axially displaceable piston. The drug delivery device comprises a housing, a stationary capacitive sensor assembly, and a moveable indicator element comprising a surface with a code pattern detectable by the stationary capacitive sensor. The code pattern is formed from conductive markings printed onto the surface. The capacitive sensor is formed on a flexible sheet mounted at least in part to the exterior of the housing.
    Type: Grant
    Filed: November 9, 2016
    Date of Patent: December 1, 2020
    Assignee: Novo Nordisk A/S
    Inventors: Andre Larsen, Henrik Riehm Soerensen
  • Patent number: 10814067
    Abstract: A drug delivery device is provided comprising or adapted to receive a cartridge with an axially displaceable piston. The drug delivery device comprises a housing, a stationary capacitive sensor assembly, and a moveable indicator element comprising a surface with a code pattern detectable by the stationary capacitive sensor. The code pattern is formed from conductive markings printed onto the surface. The capacitive sensor is formed on a flexible sheet mounted at least in part to the exterior of the housing.
    Type: Grant
    Filed: November 9, 2016
    Date of Patent: October 27, 2020
    Assignee: Novo Nordisk A/S
    Inventors: Andre Larsen, Henrik Riehm Soerensen
  • Publication number: 20200197615
    Abstract: A drug delivery device is provided comprising a drug-filled cartridge or means for receiving a drug-filled cartridge, and drug expelling means comprising expelling means for expelling an amount of drug from the cartridge, and an indicator member arranged to move corresponding to an action performed on or by the drug delivery device. The device further comprises an energy source, wireless communication means, sensor means adapted to detect movement of the indicator member, and a processor adapted to (i) receive input from the drug delivery device indicative of indicator member movement and (ii) control the communication means to transmit a data signal comprising coded information derived from received input from the sensor means, wherein the wireless communication means is in the form of a sound transducer.
    Type: Application
    Filed: May 4, 2018
    Publication date: June 25, 2020
    Inventor: Andre Larsen
  • Publication number: 20200086052
    Abstract: A cap assembly adapted to be attached to a drug delivery device main unit, comprising a drug-filled cartridge with an axially moveable piston and a distal portion with a needle penetratable seal, a needle assembly and a cap. The needle assembly comprises a needle having a distal skin-piercing end and a proximal seal-piercing end. The cap comprises a reservoir adapted to receive the needle distal end, the cap accommodating the needle assembly and at least the distal portion of the cartridge. The needle assembly and the cartridge are arranged axially moveable relative to each other between an initial state in which the proximal needle end is arranged distally of the cartridge seal, and an operational state in which the proximal needle end has penetrated the cartridge seal, wherein the reservoir is adapted to receive drug from the cartridge via the needle.
    Type: Application
    Filed: March 14, 2018
    Publication date: March 19, 2020
    Inventor: Andre Larsen
  • Patent number: 10556066
    Abstract: An assembly comprises an electric consumer, an electric voltage source adapted to power the electric consumer, and user operated actuation means. The electric voltage source is operatable between a first state in which a first voltage is generated and a second state in which a second higher voltage is generated. The user operated actuation means is operatable from a first to a second state and adapted to thereby operate the electric voltage source from the first to the second state, and operatable from the second state to the first state and adapted to thereby operate the electric voltage source from the second to the first state.
    Type: Grant
    Filed: May 26, 2016
    Date of Patent: February 11, 2020
    Assignee: Novo Nordisk A/S
    Inventor: Andre Larsen
  • Publication number: 20190117900
    Abstract: A drug delivery device is provided comprising or adapted to receive a cartridge with an axially displaceable piston. The drug delivery device comprises a housing, a stationary capacitive sensor assembly, and a moveable indicator element comprising a surface with a code pattern detectable by the stationary capacitive sensor. The code pattern is formed from conductive markings printed onto the surface. The capacitive sensor is formed on a flexible sheet mounted at least in part to the exterior of the housing.
    Type: Application
    Filed: November 9, 2016
    Publication date: April 25, 2019
    Applicant: Novo Nordisk A/S
    Inventor: Andre Larsen
  • Patent number: 10226577
    Abstract: A drug delivery device is provided comprising a housing having an exterior surface, a drug-filled reservoir with an outlet, drug expelling means, and a flexible sheet. On the flexible sheet is formed or mounted input means adapted to be actuated corresponding to an event indicative of drug being expelled, a display adapted to display a time parameter, a processor, and an energy source. The processor is adapted to, based on input from the detection means, control the display to display a time parameter related to the time the event was detected, and the flexible sheet is attached at least in part to the outer surface of the housing.
    Type: Grant
    Filed: November 13, 2014
    Date of Patent: March 12, 2019
    Assignee: Novo Nordisk A/S
    Inventors: Bo Radmer, Andre Larsen, Mikkel Avlund, Morten Revsgaard Frederiksen
  • Publication number: 20190022331
    Abstract: Method of manufacturing a drug delivery device, comprising the steps of (i) providing a plurality of components which in an assembled state form a processor-controlled drug delivery device, (ii) determining a parameter value for at least one component, (iii) assembling the components to form a drug delivery device, and (iv) storing in the processor memory correction data, the correction data being based on one or more differences between a determined parameter value and a corresponding nominal value.
    Type: Application
    Filed: August 30, 2016
    Publication date: January 24, 2019
    Inventor: Andre Larsen
  • Patent number: 10166338
    Abstract: A system comprising first and second drug delivery devices (1) based on the same technology platform, each comprising a main portion (3) with a reservoir holding a type of drug, a drug outlet, and drug expelling means for expelling drug from the reservoir through the drug outlet, as well as a cap (100) releasably mountable to the main portion to enclose the drug outlet, each cap comprising a unique user-identifiable marking indicating the corresponding type of drug. The cap and main portion of each drug delivery device comprise a pair of corresponding key structures preventing the first cap from being mounted on the second main portion, and the second cap from being mounted on the first main portion.
    Type: Grant
    Filed: September 9, 2010
    Date of Patent: January 1, 2019
    Assignee: Novo Nordisk A/S
    Inventors: Karsten Baker Nielsen, Andre Larsen
  • Patent number: 10155090
    Abstract: System comprising a sensor assembly (3, 4, 5, 6) adapted to measure a magnetic field, and a moveable element (1) adapted to be moved relative to the sensor assembly between two positions by a combined axial and rotational movement, the rotational movement having a pre-determined relationship to the axial movement. A magnet (3) is mounted to the moveable element and configured to generate a spatial magnetic field which relative to the sensor assembly varies corresponding to both the axial and rotational movement of the magnet and thus the moveable element. A processor is configured to determine on the basis of measured values for the magnetic field an axial position of the moveable element.
    Type: Grant
    Filed: October 5, 2012
    Date of Patent: December 18, 2018
    Assignee: Novo Nordisk A/S
    Inventors: Andre Larsen, Henrik Riehm Soerensen, Laurits Hoejgaard Olesen, Nikolaj Frogner Krusell, Jens Christian Andersen
  • Publication number: 20180117259
    Abstract: An assembly comprises an electric consumer, an electric voltage source adapted to power the electric consumer, and user operated actuation means. The electric voltage source is operatable between a first state in which a first voltage is generated and a second state in which a second higher voltage is generated. The user operated actuation means is operatable from a first to a second state and adapted to thereby operate the electric voltage source from the first to the second state, and operatable from the second state to the first state and adapted to thereby operate the electric voltage source from the second to the first state.
    Type: Application
    Filed: May 26, 2016
    Publication date: May 3, 2018
    Inventor: Andre Larsen
  • Patent number: 9822455
    Abstract: A regular metallic, cylindrical tubular needle cannula (1) is subjected to a metal etching liquid (21) in the inside lumen (4) thereby increasing the inside diameter and enhancing the flow properties while maintaining the outside appearance. The inside diameter is only increased over a controlled length (7) of the full length of the needle cannula (1) leaving sufficient length and wall thickness to also taper the outside diameter.
    Type: Grant
    Filed: September 20, 2010
    Date of Patent: November 21, 2017
    Assignee: Novo Nordisk A/S
    Inventors: Andre Larsen, Lasse Wengel Christoffersen, Mikael Andersen, Jan Harald Preuthun